IN THE NEWS
Decode Health Expands Strategic Advisory Board
New members bring cross-industry insights to the company Nashville, Tenn. – Nov. 11, 2020 – Chase Spurlock, PhD, founder and CEO of Decode Health, announced the addition of two members to the company's Strategic Advisory Board. New members Cynthia Kilroy and Dr. Franklin Cockerill expand the depth and breadth of industries [read more...]
Local Startup Develops AI Platform for Predicting COVID-19 Trends
One-year-old technology startup Decode Health has developed a predictive artificial intelligence platform that identifies emerging trends in the COVID-19 outbreak, providing governments and other organizations early insights to where resources need to be allocated to provide targeted outreach among high-risk populations.
Decode Health Launches Eight-Person Strategic Advisory Board Chaired by Dr. Alan Spiro
Board members advise on applications of the company’s AI solution and strategic partnerships
BLOG POSTS
OUR ABSTRACTS
OUR PUBLICATIONS
RECENT PODCASTS
WEBINARS
Next-generation RNA sequencing unlocks the discovery of novel candidate biomarkers for diagnostic and therapeutic applications, but reproducibility is a key challenge in biomarker discovery programs. Integrating multi-faceted quality control (QC) steps can improve design decisions and enhance the confidence and reliability of results. This webinar will demonstrate how a comprehensive QC framework supports a disease-agnostic biomarker discovery program to identify biologically relevant candidate biomarkers of complex disease and how this framework can be adapted for total RNA sequencing of whole blood, plasma, and serum samples.
